Discover trends, market shifts, and competitive outlooks for the antiparasitic drugs industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Antiparasitic Drugs Market From 2025 To 2029?

There has been a robust growth in the size of the antiparasitic drugs market in the past few years. The market is projected to expand from $24.06 billion in 2024 to $25.75 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. The significant progress in the previous period was a result of the prevalence of parasitic infections, resistance to current treatments, and global health initiatives.

The market for antiparasitic drugs is anticipated to experience considerable growth in the upcoming years, with projections suggesting it will rise to $33.64 billion by 2029, showing a compound annual growth rate (CAGR) of 6.9%. This growth within the prediction period can be linked to several factors such as the emergence of new parasitic threats, changes in climate, and vector-borne diseases, as well as heightened emphasis on worldwide health security and healthcare accessibility. Noteworthy trends set to impact the market in the forecast period encompass advancements in the development of drugs, focused therapy tactics, combination therapies, collaborations between the public and private sectors, telemedicine, and distance diagnosis.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp

Which Primay Drivers Are Accelerating Growth in the Antiparasitic Drugs Market?

The escalating occurrence of vector-borne diseases is predicted to boost the growth of the antiparasitic drugs market in the future. These diseases include infections transferred from humans to other animals through the bite of arthropods, mainly insects like mosquitoes, ticks, and flies. Some prominent examples of these contagions are malaria, dengue, and yellow fever. Antiparasitic medication plays a pivotal role in halting the expansion of vector-borne diseases by pinpointing and eliminating the implicated parasites. Notably, chloroquine, doxycycline, and atovaquone-proguanil, are some of the most widely used drugs for treating malaria. Further, from January to June 2024 according to data from the Centers for Disease Control and Prevention, a governmental organization in the USA, over 9.7 million cases of dengue were reported across the Americas, a figure more than twice higher than the 4.6 million cases that were reported in 2023. The USA also saw a significant number of dengue cases with Puerto Rico reporting 1,498 cases and another 745 cases identified among U.S. travelers returning from affected regions. Hence, the increasing occurrence of vector-borne diseases stimulates the growth of the antiparasitic drugs market.

Antiparasitic Drugs Market Driver: Rise in parasitic infections increases Antiparasitic Drug Market

Which Primary Segments of the Antiparasitic Drugs Market Are Driving Growth and Industry Transformations?

The antiparasitic drugs market covered in this report is segmented –

1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products

2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazoles

3) By Route of Administration: Oral, Injectable, Topical

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel

2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine

3) By Ectoparasiticides: Permethrin, Malathion, Lindane, Fipronil

4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12927&type=smp

Which Regions Are Key Players in the Growth of the Antiparasitic Drugs Market?

North America was the largest region in the antiparasitic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antiparasitic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Technological Trends Are Reshaping the Antiparasitic Drugs Industry Dynamics?

Key players in the antiparasitic drugs market, such as C.H. Boehringer Sohn AG and Co. KG, are concentrating their efforts on creating innovative products, specifically chewable veterinary medications, to make administration easier and increase pet compliance. These chewable medications, fashioned into flavorsome tablets or treats, are designed to make treatment more palatable for animals, reducing stress levels during administration. For example, in April 2024, the Germany-based pharmaceutical company launched NexGard Spectra, aiming to provide comprehensive parasite management. NexGard SPECTRA is a tasty, soft chewable that offers broad-spectrum parasite control for dogs, effectively dealing with fleas, ticks, heartworms, and a variety of intestinal worms in a once-monthly treatment. It shows swift efficacy, eliminating fleas within four hours of administration and achieving more than 99% efficiency against multiple parasites soon after.

View the full report here:

https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

What Parameters Are Used to Define the Antiparasitic Drugs Market?

Antiparasitic drugs are medications used to treat infections caused by various parasites that can infect humans, animals, or plants. Parasites are organisms that live on or within a host organism and derive their nutrients from it, often causing harm to the host in the process. Antiparasitic drugs target these parasites to either kill them or inhibit their growth.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12927

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model